semaglutide + cagrilintide GLP-1 (S) Trial Scorecard: REDEFINE 1 and
Description
Lower Nr5a2 level downregulates the -catenin and TCF-4 expression in caerulein-induced pancreatic inflammation
They are not FDA-approved and are not for human or veterinary use
Biochemical and Biophysical Research Communications, 492 , 356361
Additionally, investigations explore its interaction with pathways related to proteolytic processes and regulatory signaling molecules
